skip to Main Content
covid19

Dissecting the Role of CPCB During Covid-19 Pandemic

INTRODUCTION “I only feel angry when I see waste. When I see people throwing away things we could use.” - Mother Teresa After a decline in COVID cases in September, India saw a huge upsurge in the cases after March…

CRISPR Patent Process And Its Applicability In The Covid Era

INTRODUCTION CRISPR technology is a targeted technique that allows researchers to modify genomes with unprecedented precision, efficiency, and flexibility. This technology is at the heart of a true biotechnology revolution, with huge implications for health, agriculture, and a variety of…

IP Waiver and Covid-19 Vaccines

Since 2019, coronavirus hit the whole world and it is now for 2 years, we are facing this unfortunate pandemic. As of 27 October 2021, there is a total of 24.43cr cases and 49.61lakh deaths worldwide with the USA on…

The Pandemic and the Vaccine- Licensing Rights in Patent

The first case of novel coronavirus or COVID-19 is estimated to have first occurred at the seafood market of Wuhan, China in December 2019. Little did everyone know that the virus which was first mistaken as the common flu was…

Covid-19: Patent, Economy, Prophylaxis and Treatment

Everyone around the globe is suffering from the Covid-19 pandemic and several industries are trying to overcome the economic turmoil.There is a steep decline in product sales & product manufacturing segments, Covid-19 and worldwide lockdowns has severely affected R&D activities…

Back To Top